Japanese conductor Ozawa to undergo cancer treatment

Japanese conductor Ozawa to undergo cancer treatment

TOKYO, Japan - Prominent Japanese conductor Seiji Ozawa (2nd from L), accompanied by his primary doctor, sit for a press conference at a hotel in Tokyo on Jan. 7, 2010. Ozawa said he was diagnosed with early stage of esophageal cancer and will cancel all of his 30 concert engagements through June.

  • Product Code
  • ILEA001140121
  • Registered date
  • 2010/1/07 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2010 Kyodo News
  • Media size
  • 1799 × 1303 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 626.78(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Rocks hit climbers' backs in Mt. Ontake

    Rocks hit climbers' backs in Mt. Ontake

    NAGANO, Japan - Nagano Red Cross Hospital doctor Kaneyuki Furihata (L) and nurse Satoko Tokutake, who treated patients injured in the Mt. Ontake's eruption, speak at a press conference in Nagano City on Sept. 30, 2014. Furihata said rocks shot out of the volcano hit the victims from behind.
      Research to start on blood tests to detect 13 cancer types

      Research to start on blood tests to detect 13 cancer types

      TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
        Novartis management replaced

        Novartis management replaced

        TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
          Novartis management replaced

          Novartis management replaced

          TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
            Ghostwriter for well-known Japanese composer

            Ghostwriter for well-known Japanese composer

            TOKYO, Japan - Takashi Niigaki, a music lecturer, speaks at a press conference at a Tokyo hotel on Feb. 6, 2014, the day after confessing that he has worked as a ghostwriter for Mamoru Samuragochi, a well-known Japanese composer, for nearly 20 years. At the press conference, Niigaki cast doubt over the composer's claim that he cannot hear.
              Amari to miss key TPP talks due to cancer treatment

              Amari to miss key TPP talks due to cancer treatment

              TOKYO, Japan - Akira Amari, Japan's minister in charge of the Trans-Pacific Partnership free trade talks, announces at a press conference at the Cabinet Office in Tokyo on Dec. 5, 2013, that he will not be able to attend a TPP ministerial negotiating session starting Dec. 7 in Singapore, as he has been diagnosed with tongue cancer. Tokyo will send Amari's deputy, Yasutoshi Nishimura, senior vice minister of the Cabinet Office, instead to the four-day meeting.
                Novartis scandal

                Novartis scandal

                TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, speaks in a press conference in Tokyo on Oct. 3, 2013. At right is Yoshiyasu Ninomiya, president of Novartis Pharma K.K., a Japanese unit of Novartis AG. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.
                  Data altered in Japanese research for Novartis blood pressure drug

                  Data altered in Japanese research for Novartis blood pressure drug

                  TOKYO, Japan - Toshikazu Yoshikawa (2nd from L), president of the Kyoto Prefectural University of Medicine, and Shinji Fushiki (L), the university窶冱 vice president, bow toward the end of a press conference in Kyoto on July 11, 2013. Yoshikawa apologized as the university found that data employed in a clinical study on Novartis Pharama K.K.'s blockbuster blood pressure lowering drug Diovan were manipulated.
                    Japan doctor offers medical relief abroad

                    Japan doctor offers medical relief abroad

                    TOKYO, Japan - Nobuko Kurosaki, president of the Japanese arm of Doctors without Borders, speaks on May 21, 2013 at the entity's office in Tokyo's Shinjuku Ward. Kurosaki, who assumed her current position in March 2010, has offered humanitarian medical aid as a volunteer surgeon on a total of 11 missions to such countries as Sri Lanka, Somalia and Jordan since 2001. Most recently she was in Syria for about a month from mid-April.
                      Ozawa to become director general of Art Tower Mito

                      Ozawa to become director general of Art Tower Mito

                      TOKYO, Japan - File photo shows Japanese conductor Seiji Ozawa. Art Tower Mito in Ibaraki Prefecture said on March 31, 2013, Ozawa will become its director general on April 1.